Central Venous Access Devices for the Delivery of Systemic Anticancer Therapy: An Economic Evaluation
Open Access
- 31 October 2023
- journal article
- research article
- Published by Elsevier in Value in Health
- Vol. 27 (1) , 7-14
Abstract
No abstract availableKeywords
Funding Information
- National Institute for Health and Care Excellence
This publication has 19 references indexed in Scilit:
- Editor's Choice – Vascular Access: 2018 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS)European Journal of Vascular and Endovascular Surgery, 2018
- Approaches to interpreting and choosing the best treatments in network meta-analysesSystematic Reviews, 2017
- Covariate adjustments in randomized controlled trials increased study power and reduced biasedness of effect size estimationJournal of Clinical Epidemiology, 2016
- Hickman catheter and implantable port devices for the delivery of chemotherapy: a phase II randomised controlled trial and economic evaluationBritish Journal of Cancer, 2016
- Central venous access in oncology: ESMO Clinical Practice GuidelinesAnnals of Oncology, 2015
- Comparison of peripherally inserted central venous catheters (PICC) versus subcutaneously implanted port-chamber catheters by complication and cost for patients receiving chemotherapy for non-haematological malignanciesSupportive Care in Cancer, 2013
- CONSOLIDATED HEALTH ECONOMIC EVALUATION REPORTING STANDARDS (CHEERS) STATEMENTInternational Journal of Technology Assessment in Health Care, 2013
- Multivariate Random-effects Meta-analysisThe Stata Journal: Promoting communications on statistics and Stata, 2009
- A Comparison of Hickman Line- and Port-a-Cath-associated Complications in Patients with Solid Tumours Undergoing ChemotherapyClinical Oncology, 2007
- The Role of Cost-Consequence Analysis in Healthcare Decision-MakingPharmacoEconomics, 1998